-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Co-Diagnostics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q3 2025.
- Co-Diagnostics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was -$1.17M, a 5358% decline year-over-year.
- Co-Diagnostics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was -$1.15M, a 130% decline year-over-year.
- Co-Diagnostics, Inc. annual Income Tax Expense (Benefit) for 2024 was $57.4K.
- Co-Diagnostics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$2.78M, a 39.7% increase from 2022.
- Co-Diagnostics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$4.61M, a 151% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)